Abstract
Serum levels of TSH, thyroxine-binding globulin (TBG), T4, T3 and reverse T3 (rT3) were measured in 36 patients with fatty liver disease, 11 patients with chronic persistent hepatitis, 17 patients with chronic active hepatitis, and 29 patients with liver cirrhosis. TBG was significantly above normal levels in both groups of chronic hepatitis, the slight concomitant T4 and T3 increase was significant only for Tt in chronic persistent hepatitis. A significant decrease in T4 and T3 concentration was found in fatty liver disease and in hepatic cirrhosis. A shift in T4 conversion to rT3 could exclusively be demonstrated for the group of hepatic cirrhosis, reflected by a significant increase in rT3. As our findings indicate normal TSH levels and a lack of clinical signs of hypothyroidism in chronic liver disease, the possibility of diverse regulating changes must be considered.
Similar content being viewed by others
References
Nomura S., Pittmann C.S., Chambers J.B., Buck M.W., Shimizu T. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J. Clin. Invest. 56: 643, 1975.
Chopra I.J. An assessment of the daily production and significance of thyroidal secretion of 3, 3′, 5′-triiodothyronine (reverse T3) in man. J. Clin. Invest. 58: 32, 1976.
Kodding R., Janzen J., Schmidt F., Hesch R.D. Reverse triiodothyronine in liver disease. Lancet 2: 314, 1976.
Green J.R.B., Snitcher E.J., Mowat N.A.G., Ekins R.P., Rees L.M. Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities. Clin. Endocrinol. (Oxf.) 7: 453, 1977.
Schussler G.C., Scheffner F., Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease. N. Engl. J. Med. 299: 510, 1978.
Rudorff K.M., Herrmann J., Strohmeyer G., Kruskemper H.L Schilddrusenfunktionsparameter bei Lebererkrankun- gen. Med. Welt 29: 1888, 1978.
Weissel M., Fritzsche H., Stummvol H.K., Kolbe M., Wolf A., Seyfried M. Das Verhalten von Schilddrusenhormonkonzentrationen im Serum von Patienten mit schweren nicht- thyreoidalen Erkrankungen. Wien. Klin. Wochenschr. 90: 254, 1978.
De Groote J., Desmet V., Gedigk P., Korb P., Popper M., Poulsen H., Scheuer P.J., Schmidt M., Thaler M., Uehlinger E. A classification of chronic hepatitis. Lancet 2: 626, 1968.
Meinhold K., Wenzel K.W. Zur Methodik der direkten radioimmunologischen Be- stimmung von Trijodthyronin im Serum. Z. Klin. Chem. Klin. Biochem. 12: 477, 1974.
Meinhold H., Wenzel K.W. Radioimmunoassay of thyroxine in unextracted serum. Horm. Metab. Res. 6: 169, 1974.
Meinhold H., Wenzel K.W., Schumbrand P. Radioimmunoassay of 3, 3′, 5′ -triiodo-L-thyronine (reverse T3) in human serum and its application in different thyroid states. Z. Klin. Chem. Klin. Biochem. 13: 571, 1975.
Odell W.D., Wilber J.F., Utiger R.D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Progr. Horm. Res. 23: 47, 1967.
Ellman G.L., Courtney K.D., Andes V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88, 1961.
Dowling J-T., Freinkel N., Ingbar S.H. Thyroxine-binding by sera of pregnant women. J. Clin. Endocrinol. Metab. 16: 280, 1956.
Vannotti A., Beraud T. Functional relationship between the liver, the thyroxine-binding protein of serum, and the thyroid. J. Clin. Endocrinol. Metab. 19: 466, 1959.
Glinoer D., Gershengorn M.C., Robbins J. Thyroxine binding globulin biosynthesis in isolated monkey hepatocytes. Biochim. Biophys. Acta 418: 232, 1976.
Chopra I.J., Solomon D.H., Chopra U., Young R.T., Chua Teco G.N. Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine. J. Clin. Endocrinol. Metab. 39: 501, 1974.
Chopra I.J., Chopra U., Smith S.R., Reza M., Solomon D.M. Reciprocal changes in serum concentrations of 3, 3′, 5′-triiodothyronine (reverse T3) and 3, 3′, 5-triiodothyro-nine (T3) in systemic illnesses. J. Clin. Endocrinol. Metab. 41: 1043, 1975.
Grinberg R., Volpert E.M., Werner S.C. In vitro deiodination of labelled L-thyroxine to L-3, 5, 3′-triiodothyronine in mouse and human pituitaries. J. Clin. Endocrinol. Metab. 23: 140, 1963.
Silva J.E., Dick T.E., Larsen P.R. The contribution of local tissue thyroxine monodeiodi-nation to the nuclear 3, 5, 3′-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology 103: 1196, 1978.
Tata J.R., Rell J.E., Rawson R.W. Metabolism of L-thyroxine and L-3, 5, 3′-triiodothyro-nine by brain tissue preparations. Endocrinology 60: 83, 1957.
Nicod P., Burger A., Staeheli V., Vallotton M.B. A radioimmunoassay for 3, 3′, 5′-triiodo-L-thyronine in unextracted serum: method and clinical results. J. Clin. Endocrinol. Metab. 42: 823, 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
L’age, M., Meinhold, H., Wenzel, K.W. et al. Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases. J Endocrinol Invest 3, 379–383 (1980). https://doi.org/10.1007/BF03349374
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349374